SYRA HEALTH CORP. Increase (Decrease) in Accounts Payable, Trade
SYRA HEALTH CORP. (SYRA) reported Increase (Decrease) in Accounts Payable, Trade of -$51.93 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-09-14
- SYRA HEALTH CORP. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$170.83K, a 173.62% decline year-over-year.
- SYRA HEALTH CORP. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $118.90K, a 46.76% decline year-over-year.
- SYRA HEALTH CORP. increase (decrease) in accounts payable, trade for the quarter ending 2025-06-30 was $232.03K.
- SYRA HEALTH CORP. increase (decrease) in accounts payable, trade for the quarter ending 2025-03-31 was $223.34K, a 22.33% increase year-over-year.
- SYRA HEALTH CORP. increase (decrease) in accounts payable, trade for fiscal 2023 was $30.60K, a 92.20% decline from fiscal 2022.
- SYRA HEALTH CORP. increase (decrease) in accounts payable, trade for fiscal 2022 was $392.28K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$170.83K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-14 | -$51.93K S-1 · filed 2026-09-14 | ||
| 2026-03-31 | $118.90K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $145.83K S-1 · filed 2026-09-14 | |||
| 2025-06-30 | $232.03K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-14 | $455.37K S-1 · filed 2026-09-14 | $344.13K derived: sum of 3 quarters · filed 2026-09-14 | $56.94K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-03-31 | $223.34K 10-Q · filed 2026-05-07 | $112.10K derived: sum of 2 quarters · filed 2026-09-14 | -$175.09K derived: sum of 3 quarters · filed 2026-09-14 | -$320.54K derived: sum of 4 quarters · filed 2026-09-14 |
| 2024-12-31 | -$111.24K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14 | -$398.42K derived: sum of 2 quarters · filed 2026-09-14 | -$543.88K derived: sum of 3 quarters · filed 2026-09-14 | -$361.30K S-1 · filed 2026-09-14 |
| 2024-09-30 | -$287.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$432.64K derived: sum of 2 quarters · filed 2025-08-12 | -$250.06K 10-Q · filed 2024-10-29 | -$719.85K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-06-30 | -$145.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $37.12K 10-Q · filed 2025-08-12 | -$432.67K derived: sum of 3 quarters · filed 2025-08-12 | -$158.57K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $182.58K 10-Q · filed 2025-05-08 | -$287.21K derived: sum of 2 quarters · filed 2025-05-08 | -$13.12K derived: sum of 3 quarters · filed 2025-05-08 | $181.40K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$469.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$195.69K derived: sum of 2 quarters · filed 2025-03-11 | -$1.17K derived: sum of 3 quarters · filed 2025-03-11 | $30.60K 10-K · filed 2025-03-11 |
| 2023-09-30 | $274.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $468.62K derived: sum of 2 quarters · filed 2024-10-29 | $500.39K 10-Q · filed 2024-10-29 | $634.32K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $194.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $226.30K 10-Q · filed 2024-08-08 | $360.23K derived: sum of 3 quarters · filed 2024-08-08 | |
| 2023-03-31 | $31.77K 10-Q · filed 2024-05-09 | $165.70K derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $133.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $392.28K 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $258.35K 10-Q · filed 2023-11-14 |